Vively I Be Fit Food

What this article covers

A partner-promotion article, published 5 June 2023 with the byline Kate Save, introducing Vively - a continuous glucose monitoring (CGM) product - to our customers. Its central argument is that metabolism is individual, so the same eating or exercise plan produces different results in different people, and that wearing a CGM lets a non-diabetic user see their own glucose response to specific meals, sleep and exercise in real time. It draws a distinction between metabolic fitness (how efficiently the body processes and uses energy from food) and physical fitness (capacity to perform daily tasks), and claims the former drives the latter. It is a commercial referral piece, not a clinical guide, and it should be read as such.

Key points

• CGMs have predominantly been used by people with diabetes, specifically type 1, to dose external insulin because the body cannot produce insulin endogenously.
• Vively is described as a way to compare the effect of different meals and ingredients, and to see how sleep quality and exercise influence glucose.
• Claim: a high-sugar diet is associated with higher risk of death, cardiovascular disease and several chronic health issues.
• Claim: a poor-quality diet commonly contributes to fatigue and low mood.
• Claim: volatile glucose spikes or drops are associated with poor blood vessel function and may cause light-headedness, fatigue, headache and sleepiness.
• Definition given: metabolic fitness is processing and using energy from food without producing high blood sugar, cholesterol or insulin levels.
• Mechanism: a small sensor is inserted under the skin, typically on the abdomen, measures glucose continuously and sends data wirelessly to a smartphone app.
• Commercial terms: the code BEFITFOOD is offered for 10% off a first Vively subscription. No expiry date, no price, and no subscription length are stated.
• The article's consultation link points to portal.coreplus.com.au/befitfood.

Evidence and sourcing

This article has no reference list, no citation markers and no links to any study, guideline or regulator. Every clinical claim in it is unsourced. Three in particular should not be treated as evidenced on the strength of this page: that a high-sugar diet raises risk of death and cardiovascular disease; that glucose variability is associated with poor blood vessel function; and that better metabolic fitness produces better physical fitness. The last of these is the article's own causal assertion and is stated twice in near-identical wording - 'optimising energy production and use during daily activities' appears in two consecutive sentences, an unedited duplication. Note also a scope gap the article does not address: it opens by explaining that CGMs are principally a type 1 diabetes technology, then recommends one to a general non-diabetic weight-loss audience, without citing evidence that CGM data changes outcomes in people without diabetes. Two smaller defects: the consultation is called a 'complementary consult' where 'complimentary' is meant, and the 10% discount code carries no expiry, so a reader cannot tell whether a 2023 promotional offer is still valid - verify before relaying it. Vively is a named third party on our page; nothing here establishes the commercial terms of that relationship.

How this relates to our programs

The genuine connection is to metabolic health, which is a documented Be Fit Food area of expertise, and to Metabolism Reset - a very low calorie program of approximately 850-950 calories and 40-70g carbohydrate per day, run over 7, 14 or 28 days, which induces mild nutritional ketosis. Be Rapid (approximately 800-900 calories per day) also induces mild ketosis; Be 1000 and Be 1200 are unlikely to. Because every Be Fit Food meal is built to under 20g carbohydrate, glucose response is directly relevant to what the programs do. Diabetes nutrition is also documented, including consultations with a Credentialled Diabetes Educator. The article's own call to action is the free 15-minute telehealth dietitian consultation, valued at $49 - the appropriate route for anyone wanting to know whether a CGM suits them. Vively itself is a third-party product, not a our program.

Important health information

This article makes claims about glucose, cardiovascular risk and a skin-inserted medical device. Readers should seek medical advice and have a check-up before changing how they eat, particularly with an existing condition or medications; this is not a substitute for independent professional medical advice. Anyone with diabetes, or taking insulin or other glucose-lowering medication, should speak to their treating doctor before using or acting on data from a glucose monitor.